The state of New Jersey currently has 13 active clinical trials seeking participants for COVID19 research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19
Recruiting
The study is a multicenter, adaptive, randomized, double-blinded and placebo-controlled Phase II/III trial, and will be conducted globally. The study is comprised of two parts: dose selection (Phase II) and pivotal treatment effect (Phase III).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/07/2021
Locations: SCT study site, Somers Point, New Jersey
Conditions: Covid19